Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment
(Alliance News) - Oxford Cannabinoid Technologies Holdings PLC announced on Thursday that its subsidiary, OCT Victoria Pty Ltd, has entered an agreement with iNGENu CRO Pty Lt to conduct a study evaluating the safety of OCT130401. Read More